PL · Planet Labs PBC · Insider Trading

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 22, 2026.

The sales were executed in multiple trades at prices ranging from $13.39 to $14.61. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 22, 2026.

The sales were executed in multiple trades at prices ranging from $15.13 to $15.49. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 14, 2026.

The sales were executed in multiple trades at prices ranging from $16.15 to $16.58. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Includes: (a) 2,052 RSUs that vest in equal quarterly installments on the 15th of December, March and June; and (b) 6,479 RSUs which fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's next annual meeting of stockholders to occur following the grant. The RSUs represent a contingent right to receive one share of the issuer's Class A Common Stock each and have no expiration date.

The reported transaction represents a bona fide gift. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.

Includes 1,693,566 RSUs that remain to vest in equal quarterly installments on the 15th of March, June, September and December. The RSUs represent a contingent right to receive one share of Issuer's Class A Common Stock each and have no expiration date.

This transaction involved a transfer of shares by the Reporting Person to Johnson Joint Revocable Trust, a revocable trust of which the Reporting Person and her spouse serve as trustees.

This transaction involved a transfer of shares by the Reporting Person to Ulysses Trust, a revocable trust of which the Reporting Person and his spouse serve as trustees.

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 23, 2026.

The sales were executed in multiple trades at prices ranging from $16.29 to $17.26. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

This transaction involved a transfer of shares by the Reporting Person to Ulysses Trust, a revocable trust of which the Reporting Person and his spouse serve as trustees.

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 23, 2026.

The sales were executed in multiple trades at prices ranging from $16.28 to $17.26. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

This transaction involved a transfer of shares by the Reporting Person to Johnson Joint Revocable Trust, a revocable trust of which the Reporting Person and her spouse serve as trustees.

No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Class A Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of restricted stock units ("RSUs").

Includes 977,670 RSUs that vest in equal quarterly installments on the 15th of March, June, September and December. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

Represents shares acquired upon the vesting of performance restricted stock units ("PRSUs") that were received in lieu of the Reporting Person's cash bonus earned for the first half of fiscal year ending January 31, 2027 ("H1") under the Issuer's Amended & Restated Annual Cash Incentive Plan. The Reporting Person elected to convert such cash bonus into PRSUs representing 100% of the earned cash bonus amount for H1.

No shares were sold by the reporting person. This transaction represents shares of issuer's Class A Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of performance restricted stock units ("PRSUs").

No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Class A Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of restricted stock units ("RSUs").

Includes 1,693,566 RSUs that remain to vest in equal quarterly installments on the 15th of March, June, September and December. The RSUs represent a contingent right to receive one share of Issuer's Class A Common Stock each and have no expiration date.

No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Class A Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of restricted stock units ("RSUs").

Includes 638,627 RSUs that vest in equal quarterly installments on the 15th of March, June, September and December. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

The reported transaction represents a bona fide gift. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.

This transaction involved a transfer of shares by the Reporting Person to Johnson Joint Revocable Trust, a revocable trust of which the Reporting Person and her spouse serve as trustees.

This transaction involved a transfer of shares by the Reporting Person to Johnson Joint Revocable Trust, a revocable trust of which the Reporting Person and her spouse serve as trustees.

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 23, 2026.

The sales were executed in multiple trades at prices ranging from $22.0804 to $23.0803. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 23, 2026.

The sales were executed in multiple trades at prices ranging from $22.0804 to $23.0803. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Includes 1,132,122 RSUs that vest in equal quarterly installments on the 15th of March, June, September and December. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

This transaction involved a transfer of shares by the Reporting Person to The Gary and Kristen Robinson Trust DTD 1/3/2007, a revocable trust of which the Reporting Person and her spouse serve as trustees.

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 22, 2026.

The sales were executed in multiple trades at prices ranging from $24.31 to $26.45. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price

This transaction involved a transfer of shares by the Reporting Person to The Gary and Kristen Robinson Trust DTD 1/3/2007, a revocable trust of which the Reporting Person and her spouse serve as trustees.

This transaction involved a transfer of shares by the Reporting Person to Raymond Family Rev Trust U/A DTD 05/30/2023, a revocable trust of which the Reporting Person and his spouse serve as trustees.

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 22, 2026.

The sales were executed in multiple trades at prices ranging from $25.69 to $26.89. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

This transaction involved a transfer of shares by the Reporting Person to Raymond Family Rev Trust U/A DTD 05/30/2023, a revocable trust of which the Reporting Person and his spouse serve as trustees.

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2025.

Includes 744,984 RSUs that vest in equal quarterly installments on the 15th of March, June, September and December. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 12, 2025.

The sales were executed in multiple trades at prices ranging from $25.33 to $27.17. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Includes 1,958,187 RSUs that vest in equal quarterly installments on the 15th of March, June, September and December. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

Includes 2,160 RSUs that vest in equal quarterly installments on the 15th of September, December, March and June. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

Includes (a) 2,160 RSUs that vest in equal quarterly installments on the 15th of September, December, March and June; and (b) 6,479 RSUs which fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's next annual meeting of stockholders to occur following the grant. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

Includes 6,479 restricted stock units, each of which represent a contingent right to receive one share of issuer's Class A Common Stock ("RSUs"). The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date.

Includes 2,880 RSUs that vest in equal quarterly installments on the 15th of September, December, March and June. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

Includes (a) 2,880 RSUs that vest in equal quarterly installments on the 15th of September, December, March and June; and (b) 6,479 RSUs which fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's next annual meeting of stockholders to occur following the grant. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

Includes 6,479 restricted stock units, each of which represent a contingent right to receive one share of issuer's Class A Common Stock ("RSUs"). The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date.

Includes 6,479 restricted stock units, each of which represent a contingent right to receive one share of issuer's Class A Common Stock ("RSUs"). The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date.

Includes 6,479 restricted stock units, each of which represent a contingent right to receive one share of issuer's Class A Common Stock ("RSUs"). The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date.

Includes 6,479 restricted stock units, each of which represent a contingent right to receive one share of issuer's Class A Common Stock ("RSUs"). The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date.

Includes 2,736 RSUs that vest in equal quarterly installments on the 15th of September, December, March, and June. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

Includes (a) 2,736 RSUs that vest in equal quarterly installments on the 15th of September, December, March and June; and (b) 6,479 RSUs which fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's next annual meeting of stockholders to occur following the grant. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

Includes 6,479 restricted stock units, each of which represent a contingent right to receive one share of issuer's Class A Common Stock ("RSUs"). The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date.

Includes 6,479 restricted stock units, each of which represent a contingent right to receive one share of issuer's Class A Common Stock ("RSUs"). The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date.

Includes 2,160 RSUs that vest in equal quarterly installments on the 15th of September, December, March and June. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

Includes (a) 2,160 RSUs that vest in equal quarterly installments on the 15th of September, December, March and June; and (b) 6,479 RSUs which fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's next annual meeting of stockholders to occur following the grant. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 14, 2026.

The sales were executed in multiple trades at prices ranging from $31.54 to $34.10. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Includes 32,468 RSUs which fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's next annual meeting of stockholders to occur following the grant. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Class A Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of restricted stock units ("RSUs").

Includes 1,132,122 RSUs that vest in equal quarterly installments on the 15th of March, June, September and December. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Class A Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of restricted stock units ("RSUs").

Includes 744,984 RSUs that vest in equal quarterly installments on the 15th of March, June, September and December. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Class A Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of restricted stock units ("RSUs").

Includes 1,958.188 RSUs that remain to vest in equal quarterly installments on the 15th of March, June, September and December. The RSUs represent a contingent right to receive one share of Issuer's Class A Common Stock each and have no expiration date.

The reported transaction represents a bona fide gift. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.

Includes 2,222,807 RSUs that vest in equal quarterly installments on the 15th of March, June, September and December. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

The reported transaction represents a bona fide gift. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 14, 2026.

The sales were executed in multiple trades at prices ranging from $32.86 to $35.14. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Includes (a) 3,478 RSUs that vest in equal quarterly installments on the 15th of June; and (b) 32,468 RSUs which fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's next annual meeting of stockholders to occur following the grant. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

This transaction involved a transfer of shares by the Reporting Person to The Johnson Joint Revocable Trust, of which the Reporting Person and her spouse serve as trustees.

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 12, 2025.

The sales were executed in multiple trades at prices ranging from $34.25 to $36.14. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Includes 2,222,807 RSUs that vest in equal quarterly installments on the 15th of March, June, September and December. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

This transaction involved a transfer of shares by the Reporting Person to The Johnson Joint Revocable Trust, of which the Reporting Person and her spouse serve as trustees.

Includes 1,298,687 RSUs that vest in equal quarterly installments on the 15th of March, June, September and December. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.